The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma

Insights into the biology of advanced renal cell carcinoma (aRCC) and the development of agents targeting the vascular endothelial growth factor (VEGF) pathway have positively impacted the outcomes for patients with aRCC. With the recent approval of the dual immune checkpoint inhibitors (ICIs), nivo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Asim Amin, Hans Hammers
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2019-01-01
Schriftenreihe:Frontiers in Immunology
Schlagworte:
combination immunotherapy
VEGF inhibition
immune check point inhibitor
advanced renal cell carcinoma
immuno modulation
Online Zugang:https://www.frontiersin.org/article/10.3389/fimmu.2018.03120/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge